Aberdeen Group’s Mesa Laboratories MLAB Stock Holding History

Aberdeen Group’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.5M	Buy	+101,100	New	+$11.5M	0.01%	659

Other funds holding MLAB

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.3B AUM 19.37% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Aberdeen Group's MLAB Position: Q3 2026 in Review

Aberdeen Group opened a new position in Mesa Laboratories (MLAB) in Q3 2026: 101,100 shares worth $9.5M. The stake represents 0.01% of the portfolio and ranks #659 among its holdings.

57 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

Aberdeen Group held 101,100 shares of Mesa Laboratories worth $9.5M as of Q3 2026.
Mesa Laboratories was a new Aberdeen Group position in Q3 2026.
Mesa Laboratories made up 0.01% of Aberdeen Group's portfolio in Q3 2026, its #659 holding.
57 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.